Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Smith & Nephew (SNN) Short term Debt (2014 - 2018)

Smith & Nephew (SNN) posted Short term Debt of $164.0 million for Q4 2018, up 507.41% on a QoQ basis from $27.0 million in Q4 2017, and up 507.41% year-over-year from $27.0 million in Q4 2017.

Smith & Nephew (SNN) has 4 years of Short term Debt data on file, last reported at $164.0 million in Q4 2018.

  • In Q4 2018, Short term Debt rose 507.41% year-over-year to $164.0 million; the TTM figure through Dec 2018 stood at $164.0 million (up 507.41% YoY), while the FY2018 annual figure was $164.0 million, up 507.41% from the prior year.
  • Short term Debt rose to $164.0 million in Q4 2018, from $27.0 million in the prior quarter.
  • Across five years, Short term Debt topped out at $164.0 million in Q4 2018 and bottomed at $27.0 million in Q4 2017.
  • A 4-year average of $80.8 million and a median of $66.0 million in 2015 frame the typical range for Short term Debt.
  • Annual changes were most pronounced in 2017 — Short term Debt sank 68.6% — and 2018, when it surged 507.41%.
  • Year by year, Short term Debt stood at $46.0 million in 2015, then jumped by 86.96% to $86.0 million in 2016, then sank by 68.6% to $27.0 million in 2017, then surged by 507.41% to $164.0 million in 2018.
  • The last three Short term Debt figures came in at $164.0 million (Q4 2018), $27.0 million (Q4 2017), and $86.0 million (Q4 2016), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn
10 Smith & Nephew 5.16 Bn 4.58 Bn -

Historic Data

Download Data 🔒
DateValue
Dec 31, 2018 164.00 Mn
Dec 31, 2017 27.00 Mn
Dec 31, 2016 86.00 Mn
Dec 31, 2015 46.00 Mn
Jun 30, 2015 257.00 Mn
Dec 31, 2014 54.00 Mn